Table 6a Women with a smear vs women without a smear in screen smear period, stratified according to FIGO stages, and eligibility for screening programme (aged 29–60 years, or otherwise)
From: Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases
Cervical carcinoma | Screen smear (i.e., between 1 and 6 years) a | Odds ratio | |||
|---|---|---|---|---|---|
FIGO stage | Number | Number | Percentage within stage (95% CI) | Estimate (95% CI) | P -value |
Aged 29–63 years | |||||
Stage 1A | 34 | 18 | 52.9 (35.1–70.2) | 1.39 (0.58–3.30) | 0.424 (stage 1A vs 1B) |
Stage 1B | 95 | 58 | 61.1 (50.5–70.9) | 0.35 (0.15–0.80) | 0.009 (stage 1B vs 2A–2B) |
Stages 2A–2B | 42 | 15 | 35.7 (21.6–52.0) | 0.24 (0.41–1.05) | 0.047 (stages 2A–2B vs 3A–4) |
Stages 3A–4 | 25 | 3 | 12.0 (2.5–31.2) | — | |
Stage unknown | 21 | 5 | 23.8 (8.2–47.2) | — | |
Total | 217 | 99 | 45.6 (38.9–52.5) | <0.001 | |
Aged <29 or >63 years | |||||
Stage 1A | 5 | 1 | 20.0 (0.5–71.6) | 1.00 (0.39–73.56) | |
Stage 1B | 10 | 2 | 20.0 (2.5–55.6) | 0.57 (0.55–8.18) | |
Stages 2A–2B | 24 | 3 | 12.5 (2.7–32.4) | — | |
Stages 3A–4 | 23 | — | — | — | |
Stage unknown | 7 | — | — | — | |
Total | 69 | 6 | 8.7 (3.3–18.0) | 0.211 | |
